Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Fresenius Aktie: Solides Q3, Ausblick angehoben (Aktiencheck) +++ FRESENIUS Aktie -3,02%

CLOVER HEALTH Aktie

 >CLOVER HEALTH Aktienkurs 
2.566 EUR    -16.2%    (Tradegate)
Ask: 2.566 EUR / 1080 Stück
Bid: 2.501 EUR / 1000 Stück
Tagesumsatz: 5390 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>CLOVER HEALTH Performance
1 Woche: -5,0%
1 Monat: +41,2%
3 Monate: +25,2%
6 Monate: +5,6%
1 Jahr: -22,4%
laufendes Jahr: -0,5%
>CLOVER HEALTH Aktie
Name:  CLOVER HEALTH INV. CL.A
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US18914F1030 / A2QJXX
Symbol/ Ticker:  7QD (Frankfurt) / CLOV (NASDAQ)
Kürzel:  FRA:7QD, ETR:7QD, 7QD:GR, NASDAQ:CLOV
Index:  -
Webseite:  https://www.cloverhealth...
Profil:  Clover Health Investments Corp. is a next-generati..
>Volltext..
Marktkapitalisierung:  1641.42 Mio. EUR
Unternehmenswert:  1641.42 Mio. EUR
Umsatz:  1399.3 Mio. EUR
EBITDA:  -
Nettogewinn:  -37.51 Mio. EUR
Gewinn je Aktie:  -0.08 EUR
Schulden:  -
Liquide Mittel:  164.18 Mio. EUR
Operativer Cashflow:  -40.67 Mio. EUR
Bargeldquote:  -
Umsatzwachstum:  -13.5%
Gewinnwachstum:  68.32%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 49.755 USD.
Suchwörter:  CLOVER HEALTH
Letzte Datenerhebung:  05.11.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 420.14 Mio. St.
Frei handelbar: 91.78%
Rückkaufquote: 2.67%
Mitarbeiter: 570
Umsatz/Mitarb.: 2.09 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -7.05%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.16
KBV: 5.14
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -2.62%
Operative Marge: -2.65%
Managementeffizenz:
Gesamtkaprendite: -6.74%
Eigenkaprendite: -12.59%
>Peer Group

Es sind 597 Aktien bekannt.
 
05.11.25 - 04:13
Clover Health outlines 33% membership growth outlook and targets adjusted EBITDA expansion amid utilization headwinds (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 01:45
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3 (Zacks)
 
Clover Health Investments (CLOV) delivered earnings and revenue surprises of -100.00% and +4.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.11.25 - 01:18
Clover Health Surges: Profit, Revenue, Membership Up (24/7 Wall St.)
 
Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.Yet the stock's initial reaction suggested investors remained skeptical about the durability of that turnaround. Revenue climbed to $478.0M, topping estimates of $468.3M, while the company ... Clover Health Surges: Profit, Revenue, Membership Up The post Clover Health Surges: Profit, Revenue, Membership Up appeared first on 24/7 Wall St.....
05.11.25 - 00:24
Clover Health verfehlt Gewinnprognose für Q3 2025 – Aktie gibt nach (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.25 - 22:18
Clover Health GAAP EPS of -$0.05 misses by $0.02, revenue of $496.7M beats by $25.62M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.10.25 - 21:09
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service (GlobeNewswire EN)
 
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025....
24.10.25 - 17:27
Clover Health jumps 19%; options activity could be why (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 19:45
Clover Health Investments (CLOV) Upgraded to Buy: Here′s What You Should Know (Zacks)
 
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....
22.10.25 - 22:33
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference (GlobeNewswire EN)
 
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time....
22.10.25 - 02:01
Insiderhandel: CEO, Medicare Advantage verkauft Aktien von Clover Health Investments im Wert von 44423 USD (Insiderkauf)
 
Reynoso, Jamie L. - Vorstand - Tag der Transaktion: 2025-10-17...
15.10.25 - 14:33
Clover Health′s 2026 Medicare Advantage Plans Champion Affordability and Choice (GlobeNewswire EN)
 
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value...
14.10.25 - 14:33
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners (GlobeNewswire EN)
 
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans...
09.10.25 - 22:57
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027 (GlobeNewswire EN)
 
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent of Star ratings...
08.10.25 - 05:01
Insiderhandel: CEO, Medicare Advantage verkauft Aktien von Clover Health Investments im Wert von 5332 USD (Insiderkauf)
 
Reynoso, Jamie L. - Vorstand - Tag der Transaktion: 2025-10-07...
07.10.25 - 14:33
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire EN)
 
WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced that it will release its financial results after the market closes on Tuesday, November 4, 2025. The Company's management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance for the quarter....
20.09.25 - 03:01
Insiderhandel: CEO, Medicare Advantage verkauft Aktien von Clover Health Investments im Wert von 15184 USD (Insiderkauf)
 
Reynoso, Jamie L. - Vorstand - Tag der Transaktion: 2025-09-17...
18.09.25 - 14:33
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries (GlobeNewswire EN)
 
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades...
16.09.25 - 14:33
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience (GlobeNewswire EN)
 
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements...
03.09.25 - 20:24
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way (GlobeNewswire EN)
 
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to deliver testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health, positioning Clover as a national leader in AI-enabled healthcare transformation. In his testimony, Andrew highlighted how Clover's proprietary AI platform empowers physicians to deliver more personalized, timely care at the point of service, particularly to seniors in rural and other underserved communities. Motivated by a personal mission to improve care delivery following the loss of his father to complications from uncoordinated care, Andrew shared how Clover uses technology to simplify the healthcare experience and bring smarter, more proactive care to those who need it most....
21.08.25 - 17:30
Bears are Losing Control Over Clover Health Investments (CLOV), Here′s Why It′s a ′Buy′ Now (Zacks)
 
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!